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Abstract
Background: The retinoblastoma protein (Rb) is a crucial regulator of cell cycle progression by binding with E2F
transcription factor and repressing the expression of a variety of genes required for the G1-S phase transition.
Methodology/Principal Findings: Here we show that Rb and E2F1 directly participate in the control of initiation of DNA
replication in human HeLa, U2OS and T98G cells by specifically binding to origins of DNA replication in a cell cycle regulated
manner. We show that, both in vitro and inside the cells, the largest subunit of the origin recognition complex (Orc1)
specifically binds hypo-phosphorylated Rb and that this interaction is competitive with the binding of Rb to E2F1. The
displacement of Rb-bound Orc1 by E2F1 at origins of DNA replication marks the progression of the G1 phase of the cell
cycle toward the G1-S border.
Conclusions/Significance: The participation of Rb and E2F1 in the formation of the multiprotein complex that binds origins
of DNA replication in mammalian cells appears to represent an effective mechanism to couple the expression of genes
required for cell cycle progression to the activation of DNA replication.
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Introduction
Fundamental work initially carried out in S. cerevisiae and then
extended to other organisms, has shown that origins of DNA
replication are the sites at which the ordered assembly of the multi-
protein pre-replicative complex (pre-RC) takes place. During the
G1 phase of the cell cycle, the six-subunit origin recognition
complex (ORC) is first recruited onto DNA; the CDC6 and Cdt1
proteins are then required together for loading the putative
replicative helicase (Mcm2-7) onto chromatin. Initiation of DNA
replication occurs throughthefunctionofCdc7 andS-phase CDKs,
which activate the pre-RC and promote further recruitment of
proteins required for DNA synthesis [1,2]. In S. cerevisiae, origin
selection is essentially dictated by the binding of ORC to a specific,
A/T rich, 11-bp DNA sequence. In higher eukaryotes, however,
despite the impressive conservation of proteins participating in the
pre-RC formation, primary DNA sequence recognition by ORC is
loose, and origin selection requires further information beyond
ORC-DNA interaction, possibly indicating that other proteins
participate in ORC positioning either directly or through the
induction of epigenetic modifications of chromatin [3].
The expression of a large number of factors that participate in
the formation of the pre-RC, or that are required for the G1-S
transition and the progression of the replicative fork, is
transcriptionally controlled by the interaction of the E2F1-3
transcription factors with the retinoblastoma (Rb) protein. In early
G1 cells, E2F-bound, hypo-phosphorylated Rb inhibits E2F
activity through both direct and indirect mechanisms, which
include masking the E2F activation domain or recruiting
transcriptional repressors and chromatin modifiers [4,5]. Upon
phosphorylation by the G1 phase CDKs, repression by Rb is
relieved and transcription of the E2F-target genes ensues. This is,
therefore, an effective mechanism to couple cell cycle progression
to the expression of genes that are required for DNA replication.
Over the last few years, however, a few observations have
indicated that E2F and Rb might also participate more directly in
the regulation of DNA replication. Rb was found to affect the
spatial organization of DNA replication in primary mammalian
cells [6] and to prevent genomic re-replication in cells experienc-
ing S phase DNA damage, G2/M arrest and M phase block [7,8].
More specifically, in cells irradiated in early S phase, Rb was found
associated with an early firing origin of DNA replication (the
Lamin B2 origin) during the S-phase block, and then with
additional origins in the order in which they fired [9]. Finally, and
most notably, studies performed in D. melanogaster have shown
that the E2F1 and Rb homologues form a complex with
Drosophila ORC and associate with the chorion gene cluster
origin of DNA replication, thereby limiting the physiological
amplification of this cluster in ovarian follicle cells [10,11].
Taken collectively, this information strongly suggests that E2F
and Rb might be part of the complex of proteins that associate
with origins of DNA replication also in vertebrates. Indeed, here
we show that both Rb and E2F1 bind three human origins of
DNA replication and that this association is strictly regulated
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cells, the largest ORC subunit (Orc1) directly interacts with the
under-phosphorylated form of Rb, and that this interaction is
mutually exclusive with the binding of Rb to E2F1. Consistent
with these findings, down-regulation of Orc1 by RNA interference
in human cells favors E2F1 recruitment onto origins and induces a
marked G1 arrest.
Results
Rb and E2F1 proteins are recruited to human origins of
DNA replication
We investigated recruitment of E2F and Rb to three human
origins of DNA replication that our laboratory has described in
molecular detail over the last few years. One of these origins
encompasses the 39 end of the lamin B2 gene and the promoter of
the downstream TIMM13 gene in chromosome 19q – Lamin B2
origin [12,13]; the other two origins (GM-CSF Ori1 and Ori2) are
located downstream of the GM-CSF gene in human chromosome
5q [14]. Using a high resolution chromatin immunoprecipitation
(ChIP) procedure, we have recently mapped the regions of binding
of several components of the pre-RC, including Orc1, Orc2,
Mcm5 and CDC6, at these origins in close correspondence to the
sites of nascent DNA synthesis [14].
Cross-linked chromatin from asynchronous HeLa cells was
immunoprecipitated with antibodies against Rb, E2F1, Orc1 and
Orc2 proteins. Sequence-specific primer and probe sets for real
time PCR analysis were designed to amplify and detect origin-
specific regions (B48 and B48bis for the Lamin B2 origin and
regions #16, #17 and #23 for the GM-CSF origins), as well as
non-origin areas (B10 and B13, flanking the Lamin B2 ori, and
#21 and #24 for the two GM-CSF origins); Figs. 1A and 1C.
These ChIP experiments revealed that, for all the three analyzed
origins, origin DNA was enriched 2–5 times over control by
immunoprecipitating chromatin with antibodies recognizing Rb
and E2F1 (Figs. 1B and 1D for Lamin B2 and GMS-CSF origins
respectively).
Orc1 specifically interacts with Rb in vitro and competes
with E2F1 for binding
To understand the mechanisms of Rb and E2F1 recruitment
onto origin DNA, we initially studied the interactions between the
two proteins and different components of the pre-RC by GST-
pulldown experiments. We found that [
35S]-labeled human Orc1
was specifically retained on GST-Rb immobilized on glutathione
agarose beads. In particular, Orc1 specifically interacted with the
C-terminal (aa. 379–928), but not with the N-terminal (aa. 1–400)
half of the protein (Fig. 2A). In the same experiments, binding
E2F1 to Orc1 or either E2F1 or Rb (379–928) to Orc2 were all
negative (Figs. 2A and 2B; Coomassie stained gels are shown in
Figure S1).
The C-terminus of Rb contains the A and B pocket domains,
which are common to the other members of the pocket proteins
family, p107 and p130 [15], while the additional C domain is
specific to Rb (Fig. 2C). By using fusion proteins corresponding to
the pocket domains of Rb, p107 and p130, we observed that
binding to Orc1 was specific for Rb only; in the same experiment,
Orc2 binding was negative in all proteins (Fig. 2C).
To better characterize the domains in the C-terminal portion of
Rb that are responsible for Orc1 binding, we obtained a series of
GST fusion proteins carrying the whole Rb C-terminus (fragment
AE in Fig. 2D), the A and B pocket domains (fragment AB) or
only the C-terminus (fragment SE). These proteins were tested for
binding to radiolabeled Orc1. We found that the integrity of the
C-terminal domain of Rb was essential for binding to Orc1;
indeed, the Rb C-terminus alone also retained partial capacity to
bind Orc1 (Fig. 2D). These results are in agreement with the
observation that binding to Orc1 is specific to Rb but not to other
pocket proteins.
We then sought to identify the Orc1 protein motifs responsible
for the association with Rb. Orc1 is known to have a modular
structure, conserved in most species, that includes a BAH and an
ATPase domain located at the N- and C-terminal regions of the
protein, respectively; a region interacting with the HP1 protein
partially overlaps with the BAH motif [16]. We constructed a
series of Orc1 mutants carrying various deletions in these domains,
as schematically shown in Fig. 2E, and obtained them as labeled
proteins. Neither the N-terminus (aa 1–144) nor the C-terminus
(aa 529–861) of Orc1 alone were sufficient for binding. Fragment
270–861 was capable of binding to Rb to the same extent as the
full-length protein, suggesting that an interacting domain was
between aa 270 and 528. Since fragment 151–269 still showed
residual binding, residues before aa 270 are also likely to
contribute to binding.
Different cellular proteins are known to bind Rb through a
conserved LxCxE motif [17]. Intriguingly, Orc1 displays such a
motif starting at position 504 (LPCRE), a sequence that is
absolutely conserved in mammals (Fig. 2G). This amino acid
stretch by itself, however, is not involved in Rb binding, since an
Orc1 protein mutated at this sequence (LPGRK) was still capable
of binding the whole Rb C-terminus (AE domain in Fig. 2G).
Binding of this mutant, however, was impaired for the C-terminus
SE fragment, possibly suggesting that LxCxE region, albeit not
essential, might still participate in binding. The cysteine at position
706 of Rb was reported to be essential for binding to LxCxE motif-
containing proteins such as the SV40 large T antigen [18,19],
possibly due to the destabilization of the Rb C-terminus [19]. An
Rb C706F mutant, however, was still found capable of binding
Orc1 (Fig. 2D).
The observation that the integrity of the Rb C-terminus was
required for Orc1 binding raised the intriguing possibility that the
Rb/Orc1 interaction might be mutually exclusive the binding of
Rb to E2F1, which also occurs in the same region of Rb [20]
(Fig. 3A). To test this possibility, competitive GST pulldown
experiments were performed by incubating the recombinant GST-
Rb (379–928) fusion protein with in vitro translated Orc1 in the
presence of increasing amounts of in vitro translated E2F1. As
shown in Fig. 3B, E2F1 was found to compete with Orc1 for
binding to GST-Rb. In contrast, when a control luciferase protein
was used to substitute E2F1, binding of Orc1 to Rb was unaffected
(Fig. 3C). Collectively, these in vitro results indicate that binding
Orc1 i) is specific for Rb and not for other pocket family members;
ii) requires the integrity of the Rb C-terminal domain; iii) involves
the central portion of Orc1; iv) occurs in an LxCxE motif-
independent manner; v) is mutually exclusive with the binding of
Rb to E2F1.
Endogenous Orc1 forms a stable complex with hypo-
phosphorylated Rb in human cells
We proceeded to test the interaction of Orc1 and Rb inside
HeLa cells by co-immunoprecipitation experiments, and found
that endogenous Orc1 interacted with endogenous Rb, but not
with E2F1. Consistent with the results in vitro, we also observed
that both endogenous E2F1 and Orc1 co-immunoprecipitated
with Rb, and that only Rb co-immunoprecipitated with E2F1
(Fig. 4A). These results were further confirmed by transfecting an
HA-tagged version of Orc1 in HeLa cells, followed by immuno-
precipitation with an anti-HA antibody. In these conditions,
Rb Binds Orc1 at Origins
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tion to endogenous E2F1 (Fig. 4B). The same result was also
obtained in U2OS cells (Fig. 4C). In addition, we tested the
interaction of Rb with an HA-tagged protein corresponding to
Orc1 mutated in the LxCxE domain (HA-Orc1 LPGRK).
Consistent with the GST pulldown experiments, we found that
endogenous Rb still bound this mutant (Fig. 4C). Finally, we
observed that Orc1 preferentially associated with a molecular
species of Rb with an apparent molecular mass identical to the
hypo-phosphorylated form of the protein (Fig. 4D). Collectively,
these results indicate that both endogenous and transfected Orc1
form a complex with Rb in different cell types independent of the
Figure 1. Rb and E2F1 proteins are recruited to human origins of DNA replication. The schemes (A) and (C) show the genomic regions
containing the Lamin B2 origin and the two GM-CSF origins, respectively. Converging arrows indicate sets of primers. The histograms (B) and (D)s h o w
the quantification of crosslinked DNA immunoprecipitated by ChIP on the Lamin B2 and GM-CSF origins, respectively. Each graph shows the specific
amplified genomic regions from the origins and the antibodies used for ChiP experiments. The bars indicated as Control show the results obtained by
using an irrelevant antibody (normal rabbit IgG). The histograms report the results (mean and standard error of the mean, indicated by error bars) of at
least three different experiments. The results are presented as a percentage of the amounts of precipitated chromatin over input DNA. For each of the
investigated antibodies, but not for the control, the abundance of the immunoprecipitated regions investigated showed statistically significant
difference between origin and non-origin regions (B48 and B48bis for Lamin B2 Ori and #16, #17 and #23 for the GM-CSF oris; P,0.05).
doi:10.1371/journal.pone.0013720.g001
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exclusive with the binding of Rb to E2F1, and that it involves the
hypo-phosphorylated forms of Rb.
Visualization of Orc1-Rb interaction inside the cells by
fluorescence resonance energy transfer (FRET)
The presence of FRET between two proteins tagged with
optically matched pairs of fluorophores indicates direct protein-
protein interaction at distances to the order of a nanometer in vivo
(see [21] and references therein). FRET experiments were
performed by transfection with plasmids expressing different pairs
of proteins bearing the EGFP and BFP proteins fused to their N-
terminus. FRET image analysis of individual cells is shown in
Fig. 5A. For each protein pair, the upper panels show the
intracellular distribution of fluorescence at 520 nm (the peak
wavelength of EGFP emission) under excitation at 480 nm; the
lower panels show the fluorescence of the same fields at 520 nm
after excitation of BFP at 350 nm. For each protein pair,
quantitative analysis of the intensity of fluorescence of at least 10
cells was performed under the two illumination conditions. These
results are presented in the box plots below the individual Figures,
indicating the percentile distributions of FRET efficiency. These
experiments clearly revealed that Orc1 and Rb physically
interacted inside the cell’s nucleus. Other positive interactions
Figure 2. Orc1 specifically interacts with Rb in vitro. (A) GST pull-down experiment performed by incubating GST alone or GST fused to the N-
terminus (aa. 1–400)ortheC-terminus(aa.379–928)ofRb,immobilizedongluthatione-agarosebeads,withinvitrotranslated[
35S]-labelledOrc1orOrc2
proteins. The upper panel shows the quantification of the [
35S]-labelled protein after in vitro binding. The amount of radioactivity bound to the beads is
indicated as a percentage of the input material. The lower panel shows the autoradiography. The Input lanes contain the labelled proteins prior to
binding. A representative experiment of at least 3 performed is shown. (B) GST pull-down experiment performed by incubating GST, GST-Rb (379–928)
or GST-E2F1 fusion proteins on gluthatione-agarose beads with in vitro translated [
35S]-labelled Orc1 or Orc2. The results are shown as in panel (A). (C)
Binding to Orc1 is specific for Rb. The scheme on the left side shows the conserved A/B pocket domains in the three members of the RB family, which
were used as GST fusion proteins. The figure on the right side, shows the result of a GST pull-down experiment performed with these proteins, and in
vitrotranslatedOrc1andOrc2.‘‘Rb’’forshortcorrespondstotheC-terminusofRb(aa.379–928).(D)BindingtoOrc1requirestheC-terminalregionofRb.
The scheme on the left side of the figure shows the Rb truncated or mutated proteins used for mapping the domains required for binding to Orc1 (AE,
containing the A, B andC pockets; AB, A and B pockets only; SE, C pocket only; AE Cys706Phe, which does not bind LxCxE proteins). These proteins were
obtained as GST fusions and used for the GST pull-down experiment shown on the right side of the panel. (E) Schematic representation of the main
functional domains of the Orc1 protein. BAH, bromo-adjacent homology domain; HP1, HP1 binding domain; AAA, ATPase domain; HW, putative DNA
binding site. The fragments of Orc1 subsequently tested by in vitro GST pull-down are indicated by the corresponding amino acids on the left side. (F)
GSTpull-downexperiment performedwiththeOrc1fragmentsindicatedin(E),labelledbyinvitrotranslation,andchallengedtoGSTorGST-Rbproteins.
‘‘Rb’’forshortcorrespondstothe C-terminusofRb(aa. 379–928).(G) SequencealignmentshowingtheconservedLxCxEmotiffoundin the Orc1subunit
of human, rat, mouse and hamster (upper part), and GST pull-down experiment performed with the in vitro translated Orc1 LPGRK protein (mutated in
the LxCxE motif of Orc1) and the GST-fusion proteins AE, AB and SE (lower part).
doi:10.1371/journal.pone.0013720.g002
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e13720Figure 3. E2F1 competes with Orc1 for binding to Rb. (A) Schematic representation of the regions involved in the association of Rb to Orc1
and of those that are necessary for stable association with E2F1. (B) GST pull-down experiment performed by incubating a fixed amount of in vitro
translated Orc1 together with scalar amounts of in vitro translated E2F1 with an immobilized GST fusion protein containing the ABC pocket of Rb. The
graph shows the quantification of bound E2F1 and Orc1 radioactivity; the input lanes (In) contain the labelled proteins prior to binding.
(C) Competitive GST pull-down control experiment performed with in vitro translated Orc1 and luciferase (Luc) proteins using identical experimental
conditions as in (B).
doi:10.1371/journal.pone.0013720.g003
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e13720Figure 4. Orc1 forms a stable complex with hypo-phosphorylated Rb inside the cells. (A) Co-immunoprecipitation experiments performed
with lysates from asynchronous HeLa cells using the indicated antibodies for immunoprecipitation and western blottings. (B) Immunodetection of
endogenous Rb after co-immunoprecitation with exogenous HA-tagged Orc1 in transiently transfected asynchronous HeLa cells. Additional co-
immunoprecipitations with Rb and E2F1 proteins in non-transfected and HA-Orc1-transfected HeLa cells were performed as controls. The band
marked by an asterisk (*) represents an unspecific band detected with the mouse anti-Rb antibody IF8. (C) Endogenous Rb detected by western
blotting after immunoprecipitation with anti-HA peptide antibody in non-transfected, wt HA-Orc1-, and mutant HA-Orc1 LPGRK-transfected U2OS
cells. Additional immunoprecipitations for Rb were performed as controls on the same lysates. The band marked by an asterisk (*) represents an
unspecific band detected with the mouse anti-Rb antibody IF8. (D) Immunoblotting to visualize the differently phosphorylated forms of endogenous
Rb, after immunoprecipitation with anti-Rb and anti-HA peptide antibodies in U2OS cells not transfected or transfected with wt HA-Orc1, as
indicated. Orc1 immunoprecipitated hypo-phoshorylated Rb, showing the same apparent mass as that obtained after treatment of total Rb
immunoprecipitates with PP2A phosphatase.
doi:10.1371/journal.pone.0013720.g004
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PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e13720Figure 5. FRET analysis. (A) HeLacellsweretransientlytransfectedwithexpressionvectorscodingfortheproteinsindicatedontopofeachpanelfused
toeither EGFP (green color) or BFP(blue color). Individualtransfectedcells werevisualizedbyexcitation at 480 nmandcollectionat520 nm, showingEGFP
fluorescenceafter direct EGFP excitation(panels in the upper row), and by excitation at 350 nm and collection at 520 nm, showing EGFPfluorescence after
BFP excitation, indicating FRET (panels in the lower row). The box plot below each image pair shows the quantification of FRET. Fluorescent emission at
520 nm from individual cells was recorded after excitation at 350 or 480 nm, and integrated intensities over the whole cell were evaluated. The percentile
box-plot distribution of the ratio between these two measurements is shown by considering at least 10 consecutively analyzed cells for each protein pair.
Horizontal lines of the percentile box plot distribution, from top to bottom, mark the 10th, 25th, 50th, 75th, and 90th percentile respectively. (B)F R E T
between Rb, tagged with BFP, and the same set of Orc1 truncation mutants considered for the GST pulldown experiments, tagged with EGFP.
doi:10.1371/journal.pone.0013720.g005
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Orc2, between Orc1 and E2F, or between Orc1 and either
MCM2 or MCM3. Notably, as expected, Orc1 was found to bind
Orc2, [16,22], as well as MCM2 to MCM3.
We also exploited FRET to visualize and quantify the binding of
Rb with the same set of Orc1 truncation mutants used in the GST
pulldown experiments. We found that EGFP-Orc1 (1–144) was
negative for FRET with BFP-Rb; in contrast, clear positivity was
detected for both the C-terminal fragment of Orc1 (270–861) and the
middlefragment (151–269);Fig. 5B.Theseresultsprovideaninvivo
confirmation that the Orc1 fragment 270–861 is capable of binding
to Rb to the same extent as the fulllength protein, and that binding is
also enhanced by residues extending before amino acid 270.
Orc1 and E2F1 are recruited to the lamin B2 origin at
different temporal windows of G1 phase
The finding that Rb and E2F associate with origins of DNA
replication raises the possibility that these proteins might directly
regulate origin function. To start addressing this issue, we analyzed
whether the recruitment of Rb and E2F at origins vary during the
cell cycle.
HeLa cells were synchronized in mitosis by sequential treatment
with thymidine and nocodazole, and then released from the block
and harvested at different times (Fig. 6A). The effectiveness of the
synchronization treatment to arrest cells in the M phase (0 h) was
confirmed by both their 4C DNA content and by the expression of
cyclin B1 (Figs. 6B and 6C respectively). At 5 h from release,
cells had an early G1 profile, characterized by a 2C DNA content.
At 10 h, cells were in proximity to the G1/S border, expressing
both cyclin E and A. Finally, at 15 h most cells had entered S
phase and were characterized by high level expression of cyclin A.
Orc1 was found expressed at high levels at 0, 5, and 10 h from
mitotic block release; E2F1 started to be present at 5 h and its
levels increased at 10 and 15 h; hypo-phosphorylated Rb was
detected at 0 and 5 h, while its phosphorylated forms were mainly
apparent at 10 and 15 h; Orc2 and CDC6 were present
throughout all time points (Fig. 6C).
Figure 6. Cell cycle-dependent association of Rb and E2F1 with the Lamin B2 origin. (A) Experimental scheme for HeLa cell
synchronization. HeLa cells were synchronized in mitosis by a double thymidine/nocodazole block, and then followed G1 after release from the block.
(B) Flow cytometry profiles of asynchronous cells (Asynch), cells blocked in mitosis (0 hr) or cells at different times after release. (C) Western blot
analysis of whole-cell extracts obtained from cells at different time points during synchronization. (D) Quantification of cross-linked lamin B2 origin
DNA immunoprecipitated by ChIP. On top of the graph, the antibodies used for ChIP are shown. The histogram reports the results (mean6sem) of at
least three independent experiments. The results are presented as the fold enrichment of the lamin B2 origin region (B48) over the irrelevant B10
region, after normalization for the levels of immunoprecipitated chromatin using an unrelated antibody (normal rabbit IgG) as control. (E)
Experimental scheme for T98G cell synchronization. Cells were cultured without serum for 72 h and then followed for 20 h after addition of serum. (F)
Flow cytometry profiles of asynchronous cells (Asynch), cells blocked in G0 by serum starvation (0 hr) or cells at different times after serum
stimulation. (G) Western blot analysis of whole-cell extracts obtained from cells at different times points during synchronization. (H) Results of ChIP
experiments for the lamin B2 origin, using the antibodies indicated on top of each dataset. The results are presented as in (D). AcH3: acetylated
histone H3; AcH4: acetylated histone H4.
doi:10.1371/journal.pone.0013720.g006
Rb Binds Orc1 at Origins
PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e13720The association of Rb, E2F1, Orc1 and Orc2 proteins with the
lamin B2 origin was analyzed by ChIP (Fig. 6D). In M-phase cells
(0 h), no significant enrichment was found for any of these factors
compared to chromatin immunoprecipitated with an irrelevant
antibody. Strikingly, Orc1 was found to bind the origin at 5 h (,5-
fold increase over control), and then to be progressively released
from it at 10 h (G1/S; ,3 fold increase), to return to background
levels at 15 h (S phase). In contrast, E2F1 showed reciprocal
behavior, namely commencing association with the origin as soon
as it was expressed (5 h; ,2-fold enrichment over background),
while its binding to the origin increased at 10 and 15 h (G1/S and
S respectively; ,4–5 fold enrichment). Orc2 and Rb were
constantly found associated with the origin DNA at all time points
after nocodazole block release (,2–3 fold enrichment).
To better address the study of the kinetics of E2F/Rb
recruitment to the lamin B2 origin during the G1 phase of the
cell cycle, as well as to investigate factor binding in the G0 phase,
we took advantage of the possibility to synchronize human T98G
cells in G0 by serum starvation for 72 h [23,24] (Fig. 6E). Upon
re-addition of serum, cells synchronously progressed throughout
G1 (Fig. 6F). In accordance with recently published data [24],
cyclin E and cyclin A levels started to rise in middle G1 (10 h) and
late G1 (15 hr) respectively, with both cyclins being present at
G1/S (20 h). CDC6 started to appear in middle G1; Orc1 and
Orc2 were present throughout the synchronization process, even if
the levels of the latter protein increased after middle G1. E2F1
progressively increased after middle G1, concomitant with the
appearance of hyper-phosphorylated pRb (Fig. 6G).
Immunoprecipitations were performed with chromatin cross-
linked at the different time points (Fig. 6H). In G0 cells, the only
antibody that gave significant enrichment on the lamin B2 origin
DNA was the one against Rb (,4-fold over background); binding
of Rb to the origin remained constant at all subsequent time
points. Similarly, Orc2 started to be detected (,3-fold enrichment)
in early G1 and remained rather constantly bound to the origin.
Of interest, Orc1 binding to the origin was not detectable in G0,
despite the protein being expressed; in early G1, the protein
started to associate with the origin and its enrichment peaked in
mid G1 (4–5 fold). At the later time point (15 h) it progressively
decreased to become unapparent in cells at G1/S. In contrast,
E2F1 showed opposite behaviour, since it started to associate to
the origin as early as its levels rose in G1 (,2-fold enrichment over
background in middle G1, ,4-fold in late G1, over 5-fold in late
G1). Parallel to the recruitment of E2F1 to the origin region, and
to the detachment of Orc1, the levels of chromatin acetylation,
detected using antibodies against acetylated histones H3 and H4,
were found to progressively increase over time.
Collectively, these ChIP data are concordant in showing a
reciprocal behavior of Orc1 and E2F1 recruitment onto origin
DNA. In early G1 cells, the origin is engaged in binding Rb, Orc2
and Orc1; in agreement with the G1/S boundary, Orc1 appears
to leave the complex and to be replaced by E2F1. This event
parallels the progressive acetylation of chromatin at the origin
area. Orc1 detachment from origins in correspondence of the
G1-S transition has also been recently reported by Thangavel and
coworkers [25].
Downregulation of Orc1 blocks cells in G1 and increases
binding of E2F-1 to origin DNA
Next we sought to determine whether depletion of the Orc1
protein could influence the recruitment of Orc2 (as representative
of the ORC core complex [26]) or Rb/E2F1 at origins of DNA
replication. Orc1 depletion was achieved by RNA interference on
U2OS cells. Fig. 7A shows that, despite a marked reduction
(.80%) of Orc1 protein, Orc2, Cdc6, E2F1, Rb and cyclin A and
E protein levels did not vary significantly. Interestingly, no
CDC25c protein was detectable in the Orc1 siRNA-treated cells,
and expression of the phosphorylated form of histone H2AX was
increased; both observations are consistent with the induction of a
damage checkpoint as a consequence of the Orc1 knock down.
Orc1 depletion determined a remarkable reduction in the
number of cells in the S phase of the cell cycle (from 24% to 15%
of total), and a consequent increase in the number of cells in G1
(from 61% to 68%) (Fig. 7B). Treatment with an anti-luciferase
siRNA control did not modify the cell cycle profiles. To better
document the reduction in the number of S-phase cells upon
treatment with the anti-Orc1 siRNA, we analyzed DNA synthesis
after a 1 h pulse of the siRNA-treated cells with BrdU, followed by
flow cytometry using an anti-BrdU antibody. As shown in Fig. 7C,
the number of cells with a DNA content between 2C and 4C that
incorporated BrdU (S-phase cells) was reduced from 21.5% to
14.7%, thus indicating that the consequence of the Orc1 knock
down is a marked inhibition of DNA synthesis. This inhibition was
even more pronounced in the Rb-null Saos-2 cells (from 18.1% to
7.9% cells in S-phase after Orc1 siRNA treatment; data not
shown).
In the siRNA treated cells, we studied the recruitment of Orc1,
Orc2, Rb and E2F1 to the lamin B2 origin. We found that the
binding of Orc2 and Rb was not significantly affected by the Orc1
knock down. In contrast, Orc1 depletion induced a marked
increase in E2F1 binding, as well a significant decrease of the
extent of chromatin acetylation at the origin region (Fig. 7D).
Very similar findings in terms of E2F1 binding were also detected
by analyzing the immunoprecipitated chromatin with primer pairs
detecting the two origins in the GM-CSF gene domain (Fig. 7E).
Discussion
The work presented in this manuscript presents evidence that
both Rb and E2F are part of the protein complex that is recruited
to origins of DNA replication at the G1 phase of the cell cycle.
This observation raises a series of obvious issues, including the
identification of the molecular determinants responsible for their
recruitment, the understanding of the relationship of these proteins
with the other components of the pre-RC and, most notably, the
definition of their actual function in regulating origin activity.
As shown by the immunoprecipitation experiments, Rb and
E2F1 are recruited to the lamin B2 origin as well as to the two
investigated origins downstream of the human GM-CSF gene;
enrichment for the two factors is detected at the same location
where other components of the pre-RC are found and are in close
correspondence to the sites of nascent strand DNA synthesis [14].
These three origins are rather dissimilar in both primary sequence
and chromatin context. In particular, the lamin B2 origin
encompasses a promoter and is located in a region that is
transcribed at high levels and in a constitutive manner [27]. In
contrast, GM-CSF Ori1 and GM-CSF Ori2 are located ,7K b
downstream of the GM-CSF gene, in a region that shows no
apparent transcription or canonical marks of the presence of cis-
acting transcriptional regulation elements. In addition, the three
origins show neither obvious primary sequence similarity nor the
presence of canonical E2F binding sites. Given these consider-
ations, our first speculation has been that binding Rb/E2F to the
origin region might be mediated through the interaction of either
protein with known components of the pre-RC. Indeed, our results
support the model in which Rb is bound near ORC at origins of
DNA replication by forming a specific complex with the largest
ORC subunit, Orc1. In particular, the in vitro data that
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PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e13720Figure 7. Down-regulation of Orc1 inhibits DNA replication and enhances E2F1 recruitment to origins of DNA replication. (A)
Western blotting using the indicated antibodies at 72 h after treatment of U2OS cells with siRNAs against Orc1 or luciferase (Luc) control. (B) Flow
cytometry profiles of U2OS cells treated for 72 h with the indicated siRNAs. The histogram on the right side shows the distribution of the cells in the
different phases of the cell cycle; the reduction in the number of S-phase cells after Orc1 silencing is indicated by an arrow. (C) Flow cytometry
profiles simultaneously showing detection of DNA content (propidium iodide staining) and BrdU incorporation (anti-BrdU antibody) at 72 h after
RNAi. The dashed boxes indicate BrdU positive, S-phase cells. The histogram on the right side reports the percentage of S-phase/BrdU positive cells
(mean6sem, indicated by error bars) of three different experiments. The asterisk (*) indicates significant statistical difference between ORC depletion
experiments and luciferase control experiments. (D) Results of ChIP experiments performed in U2OS cells at 72 h after siRNA silencing of Orc1. The
histograms show the quantification of origin-specific, cross-linked and immunoprecipitated DNA for the Lamin B2 origin after immunoprecipitation
using the antibodies shown below each bar pair. The results are expressed as fold of enrichment of the specific origin sequence (B48) over a
neighbouring control sequence (B10), as shown in Fig. 1A. The means6sem of at least three different experiments are shown. The asterisk (*)
indicates statistically significant differences between ORC depletion experiments and luciferase control experiments. (E) Results of ChIP experiments
performed by analyzing protein binding to the GM-CSF Ori1 and Ori2 origins in U2OS cells at 72 h after siRNA silencing of Orc1. The results are
expressed as in (D), by showing the fold of enrichment of the specific origin sequences (#17 and #23) over a neighbouring control sequence (#21),
as schematically represented in Fig. 1C.
doi:10.1371/journal.pone.0013720.g007
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that the binding of Orc1 i) is specific for Rb and not for other
pocket family members, ii) requires the integrity of the C-terminus
of Rb, iii) involves the central portion of Orc1; and iv) occurs in an
LxCxE motif-independent manner. In addition, the in vivo data
show physical interaction between Orc1 and Rb inside the nucleus
(FRET) and preferential binding of Orc1 to the hypo-phosphor-
ylated form of Rb (co-immunoprecipitations). Recent information
indicates that the Drosophila homologue of Rb (Rbf1) can also
associate with the Drosophila ORC complex and chromatin [28].
In Drosophila, however, at difference with human Rb, binding to
ORC appears to depend on the Rb N-terminus and not on the
E2F-binding region.
The recruitment of Rb to origins during the normal cell cycle
occurs at a time point at which Orc1 is not yet bound (such as at
5 h after entry into G1 phase after stimulation of serum-starved
T98G cells) or in conditions in which Orc1 is knocked down.
Thus, binding of Rb to the origin area definitely precedes, and is
thus independent from, binding of Orc1, and therefore, the
assembly of the pre-RC; what the determinants of Rb recruitment
might be, therefore, still remain elusive. In this respect, it is worth
mentioning that Rb has been shown to localize to multiple discrete
DNA foci during S phase [7] and that its docking to chromatin
might thus be dependent on its interaction with other cellular
factors. Among the over 100 factors other than E2F that
specifically bind Rb [29] there are other proteins that participate
in the DNA replication process, including MCM7, MCM4, DNA
polymerase alpha and replication factor C [19,30,31,32,33]).
Binding to these factors, however, is likely to occur at a later stage
during the origin activation process.
As far as E2F1 is concerned, our in vitro competition GST-
pulldown assays and our in vivo ChIP data along G1 phase
progression and after Orc1 knock down indicate a mutually
exclusive binding of Rb to either Orc1 (early G1) or E2F1 (late G1
and S phase). Indeed, the integrity of the whole Rb C-terminal
region, and, in particular, of the C domain, is required for both
binding to Orc1 (our findings) as well as to E2F1 [20]. The finding
that E2F1 displaces Orc1 from origin-bound Rb during late G1 is
consistent with the consolidated notion that Orc1 leaves chromatin
in late G1 and during S-phase [34]. Intriguingly, both Rb and
E2F1 have been found associated with DNA replication foci in
primary cells during early S-phase, a time point at which the
canonical regulation of Rb by G1-phase CDKs would instead
predict its dissociation from the transcription factor [35]. Indeed,
this finding is perfectly consistent with our ChIP data on origin
DNA. On this basis, we propose that the primary determinant of
E2F binding to the origin regions might not be primary DNA
sequence recognition by E2F itself, but its interaction with
chromatin-bound Rb, consistent with the information that
chromatin-bound Rb is also detected during the S-phase [36].
The finding that Rb and E2F1 associate with origins of DNA
replication raises the obvious possibility that these proteins might
directly regulate some aspects of origin function. The kinetics of
recruitment of the different factors onto the origin region, Rb and
Orc1 during early G1 phase, Rb and E2F1 during late G1, along
with other pre-RC components [37]; the preferential binding of
Orc1 to the hypo-phosphorylated form of Rb; and, finally, the
increase in chromatin acetylation that is detected when Orc1
detaches from the origin during the cell cycle or its decrease when
Orc1 is downregulated by RNAi, all suggest that the complex of
Orc1 with hypophosphorylated Rb negatively regulates origin
function. This conclusion is consistent with the observation that
mutations in the Drosophila Rb (as well as E2F) homologues fail to
limit DNA replication through their interactions with DmORC
[11]. This negative function might be exerted by a variety of
mechanisms, which recapitulate the known properties of hypopho-
sphorylated Rb, including the modulation of chromatin confor-
mation, or the direct negative regulation on components of the
replication licensing machinery.
In conclusion, our results show that Rb participates in the
formation of the protein complex that regulates DNA replication
origins during the normal cell cycle in mammalian cells, in
addition to being a major component of the intra-S-phase
checkpoint response after c-irradiation [9]. The observations that
Rb is essential for a proper spatial organization of DNA replication
in mammalian cells [6], that primary cells approaching senescence
undergo pRB-dependent, large-scale changes in chromatin
structure [38], and that cell cycle exit and terminal differentiation
are mediated by Rb [39], all raise the important question whether
the actual mechanisms mediating some of these effects might be
the specific suppression of initiation of DNA replication at origins.
Materials and Methods
Cell Culture, cell synchronization and cell cycle analysis
HeLa, T98G, U2-0S and Saos-2 cell lines (all from the ATTC -
http://www.atcc.org/) were maintained in Dulbecco’s modified
Eagle’s Medium (DMEM) with Glutamax (Life Tecnologies, Inc.)
supplemented with 10% fetal bovine serum (Life Tecnologies,
Inc.). HeLa cells were synchronized in M phase by sequential
treatment with 2.5 mM thymidine (Sigma) for 15 h, washed and
released in fresh medium for 9 h and, finally, blocked with 50 ng/
ml nocodazole (Sigma) for 15 h. For the subsequent synchroni-
zation through the G1 to the S phase, mitotic HeLa cells were
shaken-off, washed and released in fresh medium at different
times. T98G cells were synchronized by serum starvation as
described previously [40], [23]. Cells were analyzed for cell cycle
profile (DNA content) by incorporation of propidium iodide
(Sigma) and analyzed by flow cytometry on a FACSCalibur
(Becton Dickinson). Cell cycle profile distributions were deter-
mined with the Modfit LT 3.0 software.
Plasmids
The human Orc1, Orc2 and E2F1 cDNAs were obtained by
RT-PCR amplification and cloned into the pcDNA3 vector
(Invitrogen, USA). All the mutated and deleted versions of Orc1
were obtained by recombinant PCR and cloned into the pcDNA3
vector with the addition of an N-terminal HA tag. The vector
expressing GST-E2F1 has been already described [41]. The vector
expressing the 400 aa-long, GST-tagged, N-terminal fragment of
Rb is a kind gift of Dr. M. Pacek [42]. The vectors expressing the
GST fusion proteins containing the AB pockets of Rb, p107, and
p130 [43] are a kind gift of Prof. D. Cress. The vectors expressing
the GST fusion proteins of the deleted and point-mutated versions
of the large ABC pocket region of Rb (AE, AB, SE, and
AECys
706Phe) [19] were kindly provided by Prof. A. Fotedar. For
the FRET experiments, the E2F1, Orc1, Orc2, Mcm2, Mcm3 and
Rb cDNAs were obtained by PCR and subcloned in frame in
both the pEBFP-N1 and pEGFP-N1 vectors (Clontech); the
Orc1-GFP, Orc2-BFP constructs have been already described




35S]-labelled proteins used for in vitro binding assays were
produced by using the TNT Reticulocyte Lysate System or Wheat
Germ System (Promega) according to the manufacturer’s
instructions, by using the corresponding pcDNA3 vectors as
Rb Binds Orc1 at Origins
PLoS ONE | www.plosone.org 11 November 2010 | Volume 5 | Issue 11 | e13720templates. Glutahione S-transferase (GST) fusion proteins were
prepared as already described [41]. GST pulldown assays were
performed as already described [44]. Briefly, 1 mg of recombinant
proteins, after pretreatment in a solution containing DNase I
10 mU/ml and RNase A 0.2 mg/ml to remove contaminant
bacterial nucleic acids, were incubated with in vitro translated
[
35S]-proteins in a solution containing 0.1 mg/ml ethidium
bromide. Following extensive washes, the reaction mixture was
resolved by SDS-PAGE electrophoresis and radioactive proteins
were visualized by phosphoimaging (Instantimager, Packard).
Antibodies, immunobloting and immunoprecipitation
Polyclonal antibodies anti-ORC1 were produced and purified
by immunization of rabbits with a His-tagged Orc1 250–480 Aa
polypeptide [14]. Anti-Orc2 antibodies were from MBL. Mono-
clonal Anti-Rb (554136) antibodies were purchased from BD
Biosciences/Pharmingen. Rb (IF8), Rb (C-15), E2F1 (KH95),
E2F1 (C-20), Cdc6 (108.2), Cdc6 (H-304), Cyclin E (M-20), Cyclin
A (H-432), Cyclin B1 (H-433), HDAC1 (C-19) and normal rabbit
IgG (sc-2027) antibodies were from Santa Cruz Biotechnologies.
Anti-HA (3F10) antibodies were from Roche and anti-atubulin (B-
5-1-2) antibody from Sigma. The acetyl-histone H3 (06-599) and
H4 (06-866) antibodies were from Upstate. Whole cell extracts
were prepared in HNNG buffer (15 mM Hepes pH 7.5, 250 mM
NaCl, 1% NP-40, 5% glycerol, 1 mM PMSF) supplemented with
25 mM NaF, 10 mM b-glycerophosphate, 0.2 mM sodium
orthovanadate and protease inhibitors cocktail tablet (Roche) for
immunobloting. Immunoblots were carried out with 30 to 50 mgo f
whole-cell lysate. Immunoprecipitations were performed on
1–2 mg/ml of total protein lysate. Lysates for immunoprecipita-
tion were incubated overnight with the appropriate amount of
antibody (usually 1 to 2 mg) at 4uC. Immunocomplexes were
collected with protein A/G plus agarose beads (Santa Cruz
Biotechnologies), washed in HNNG buffer, treated with DNase I
(Gibco BRL) for 15 min at room temperature. Beads were
sequentially washed at 4uC with HLNG buffer (as HNNG but with
LiCl), TE buffer and finally resuspended in Laemli sample buffer.
Proteins were separated on 4–20% Tris-glycine gradient gel
(Invitrogen) and detected by immunoblotting using the enhanced
chemiluminescence systems (Super Signal West Dura Extended,
Pierce, Rockford, IL and ECL, Amersham Bioscience).
Chromatin immunoprecipitation assay
Cells were fixed by adding formaldehyde (Fluka) directly to the
cell culture medium at 1% final concentration. Cross-linking was
allowed to proceed for 7 min at 37uC and was stopped by the
addition of glycine (Sigma) at a final concentration of 125 mM.
Cells were washed and harvested in ice-cold PBS by centrifugation,
the cellular pellet was resuspended in HNNG buffer and chromatin
was sheared by sonication (average size of 0.5–1.5 kb fragments) on
ice and centrifuged to pellet debris. Immunoprecipitations were
performed as above. Protein-DNA immunocomplexes were col-
lected with protein A/G plus agarose beads (Santa Cruz
Biotechnologies), washed sequentially in HNNG buffer and HLNG
buffer, resuspended in TE buffer and treated at 100 mg/ml of
RNase A (Roche) for 30 min at 37uC. Samples were incubated for
1 h at 56uC with 0.5 mg/ml Proteinase K (Sigma), and for 15 h at
65uC to revert crosslinks. DNA was extracted with phenol:chlor-
oform:isoamyl alcohol 25:24:1 (Invitrogen), ethanol precipitated
and resuspended in 10 mM Tris HCl pH 7.5 for real time PCR.
Real Time PCR
Sequence-specific primer and probe sets for real time PCR
analysis were designed by Primer Express 1.5, in order to amplify
and detect origin as well as non-origin areas within the human
Lamin B2 and GM-CSF origins [12,14]. Using a high resolution
chroma. Real-time PCR was carried out in triplicate using
Universal Master Mix (Applied Biosystems) on an ABI Prism 7000
Sequence Detector System (Applied Biosystems). Sequence
Detector software (version 1.7) was utilized for data analysis.
Relative fold enrichment was determined by the comparative cycle
threshold (CT) method, detecting Ct difference between a target
and a standard region of interest [45].
FRET analysis
FRET analysis was conducted as previously described in detail
[21,46]. Briefly, HeLa cells were transiently transfected with
plasmids expressing GFP and BFP fusion protein pairs by the
calcium phosphate method. FRET experiments consisted in
collecting two EGFP emission signals by exciting the EGFP with
two different excitation wavelengths, 480 and 350 nm, the former
being optimal for EGFP and the latter for BFP. The background
fluorescence was measured for each field outside of the transfected
cells and subtracted. The existence of FRET was inferred by
determining the ratio between EGFP fluorescence following
excitation at 350 nm to that following excitation at 480 nm.
Confocal microscopy was performed with a Zeiss Axiovert X60
confocal microscope. Images were acquired with the LSM510
software. Data acquisition and analysis were performed using the
MetaMorph software (Universal Imaging Corporation).
RNA interference experiments
Cells were transiently transfected with smart pool siRNAs
(Dharmacon) against Orc1 for 72 h at 40 nM final concen-
tration by oligofectamine-mediated transfection (Invitrogen) fol-
lowing the manufacturer instructions. RNAi control experiments
were performed using a duplex siRNA against luciferase
(Dharmacon).
BrdU incorporation experiments
BrdU incorporation experiments were performed on cells
transiently transfected for 72 h with siRNA duplexes. Cells were
pulsed for 1 h with BrdU at final concentration of 1 mM and
BrdU-positive cells were detected by using a FITC conjugated
anti-BrdU antibody (Abcam). Cells were collected and analyzed
by double-flow cytometry analysis on a FACSCalibur (Becton
Dickinson) instrument, to simultaneously determine the cell cycle
profile (DNA content) by incorporation of propidium iodide, and
the S phase cell population by incorporation of BrdU.
Statistical analysis
One-way ANOVA and Bonferroni/Dunn’s post-hoc test was
used to compare multiple groups. Pair-wise comparison between
groups was performed using the Student’s t test.
Supporting Information
Figure S1 Coomassie stained gels corresponding to the autora-
diographs shown in Figure 2. At the end of the GST-pulldown
experiments, samples were resolved on SDS-PAGE. Gels were
then stained with Coomassie blue and dried. Radioactivity was
measured after phosphoimaging (Figure 2) while gels were
photographed and are shown here. GST fusion proteins are
indicated by (*). Panels A-D correspond to Figure 2, panels A-D
respectively; panel E to Figure 2 panel F; panel F to Figure 2 panel
G.
Found at: doi:10.1371/journal.pone.0013720.s001 (2.58 MB TIF)
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